Reuters logo
BRIEF-Novartis to showcase heart failure leadership at ESC congress with results on LCZ696
August 11, 2014 / 5:25 AM / in 3 years

BRIEF-Novartis to showcase heart failure leadership at ESC congress with results on LCZ696

Aug 11 (Reuters) - Novartis AG : * Says to showcase heart failure leadership at ESC congress 2014 with

results on new first of its type medicine LCZ696 * Says study met the primary endpoint showing LCZ696 reduced heart failure

hospitalizations along with cv deaths * Source text for Eikon * Further company coverage

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below